DsOKa_IjPcU/hqdefault.jpg' alt='Endorphin Learning Edition Register' title='Endorphin Learning Edition Register' />Rhodiola Rosea Uses, Benefits Dosage. Scientific Names Rhodiola rosea L., Sedum rosea, Rhodiola roanensis Britton. Family Crassulaceae stonecropsCommon Names Golden root, roseroot, arctic root, SHR 5, rhodaxon. Uses. Clinical trials supporting therapeutic claims are of limited quality. R. rosea may have beneficial effects in managing mild to moderate depression and mental fatigue. Results from trials evaluating adaptogenic properties and physical endurance are equivocal. Dosing. Doses used are commonly 2. For depression, doses of 3. R. rosea extract as SHR 5 have been evaluated for up to 1. Contraindications. Contraindications have not yet been identified. LiQhfOx.png' alt='Endorphin Learning Edition Register' title='Endorphin Learning Edition Register' />Browse through 14,324,115 journal and book articles on ScienceDirect. Domestic dogs are an integral part of human culture, and their welfare is an important concern for owners, caretakers, veterinarians, behavior specialists, and all. The Paleo diet is one of the most helpful healing diets for Hashimotos. Discover why it works and how to make it easier to follow. All Natural Sleeping Aids For Children O T C Sleep Aids with Sleep Aid Benadryl and Insomnia Blood Sugar Insomnia Hypnosis Ny Sleep Disorders For Teens Insomnia Video. Signs That You May Have Diabetes The 3 Step Trick that Reverses Diabetes Permanently in As Little as 11 Days. SIGNS THAT YOU MAY HAVE DIABETES The. Heroin, also known as diamorphine among other names, is an opioid most commonly used as a recreational drug for its euphoric effects. Medically it is used in several. PregnancyLactation. Information regarding safety and effectiveness in pregnancy and lactation is lacking. Interactions. None well documented. Adverse Reactions. Clinical trials report few or no adverse reactions. Information is limited. Toxicology. R. rosea was reported to be safe in acute and subacute toxicity studies. Botany. R. rosea is a perennial plant with a thick rhizome and yellow, fragrant flowers. It grows in sandy soil at high altitudes in the arctic areas of Europe and Asia, including eastern Siberia. The plant reaches a height of 3. Unique chemical constituents set R. R. rosea species. History. The Greek physician Dioscorides AD 4. De Materia Medica, renaming it from Rodia riza to Rhodiola rosea, which refers to the rose like aroma of the freshly cut root. The Swedish naturalist Carl Linnaeus 1. Groovy Download File Http. R. rosea as an astringent to treat hernia, leucorrhea, hysteria, and headache. For centuries, the plant has been used in Russia and Scandinavia, where the majority of the research has been published. The plant has also been used as a hemostatic in Tibetan folk medicine. Extract of R. rosea is registered in Russia as a medicinal product for human use. Chemistry. Three cinnamyl alcohol vicianosides rosavin, rosin, rosarin have been found to be specific to R. These 3 substances, along with rosiridin and salidroside, are the 5 marker compounds that must be present to reliably identify R. R. rosea extracts used in most clinical trials were standardized to a minimum of 3 rosavins and 0. The phenylethanol derivatives salidroside rhodioloside and tyrosol have been found in the underground part of the plants. Flavonoids in R. rosea include rodiolin, rodinin, rodiosin, acetylrodalgin, and tricin, as well as other catechins and proanthocyanidins. Monoterpenes include rosiridol and rosaridin, and triterpenes include daucosterol and beta sitosterol. Terpenes and volatile compounds have been isolated from R. Phenolic acids, including chlorogenic, hydroxycinnamic, and gallic acids, are also present. Uses and Pharmacology. Adaptogenic effects. Plant adaptogens, such as those from R. R. rosea s use in traditional Ayurvedic medicine for adaptogenic properties has been examined. Animal data. R. rosea increased the survival of freshwater snail eggs against induced stressors, including heat shock and oxidative and heavy metal stress. Injections of the plant extract administered to rats prevented stress induced elevations of beta endorphins, adrenocorticotropic hormone, cortisol, insulin, thyroxin, and triiodothyronine. Similarly, R. rosea given to rats increased swimming time up to 1. Clinical data. Positive findings were reported in a clinical trial conducted among 5. Improved sleep patterns and overall quality of sleep have been described with the use of R. Results of older trials evaluating the effect of R. R. rosea extracts. Cancer. The usefulness of R. Several antioxidant compounds have been identified in the plant, including p tyrosol, organic acids, and flavonoids. A mechanism of action has been described that includes induction of apoptosis and necrosis. Animal data. The same researchers describe experiments in animals with induced cancers. R. rosea potentiated antitumor and antimetastatic effects in mice with lung carcinoma, 3. Ehrlich tumor and Pliss lymphosarcoma, 3. Another in vitro experiment showed efficacy against prostate cancer cells in rats. Clinical data. R. N 1. 2 study. 3. Depression. Central nervous system CNS activity of R. Earlier studies found that low to medium doses of the plant had stimulatory effects while larger doses had sedative effects. In lower doses, R. CNS. R. rosea also appears to increase the permeability of the blood brain barrier to precursors of dopamine and serotonin 3. Clinical data. A systematic review of 4 clinical trials of R. The author suggests that a stimulating adaptogenic effect is responsible for antidepressant activity. A double blind, randomized clinical trial of R. Hamilton Depression Rating Scale as well as the Beck Depression Inventory. The method of action remains unclear, but is thought to be linked to mood stabilization and energy restoration. Earlier trials of varying methodology have produced conflicting results. Other effects. Antiaging. A study using the fruit fly Drosophila demonstrated increased longevity with R. Cardiac. Clinical trials are lacking. Several older experiments by a small pool of researchers investigated the antiarrhythmic and contractility effects of R. Dosage. Clinical doses are commonly 2. Doses of 3. 40 to 6. R. rosea extract as SHR 5 in depression have been evaluated for up to 1. PregnancyLactation. Information regarding safety and effectiveness in pregnancy and lactation is lacking. Interactions. None well documented. Adverse Reactions. Clinical trials report few or no adverse reactions. Information is limited. Toxicology. R. rosea has a very low level of toxicity in rats. The LD 5. 0 was calculated to be approximately 3. R. rosea was reported to be safe in acute and subacute toxicity studies. Bibliography. 1. Rhodiola rosea L. USDA, NRCS. 2. 00. The PLANTS Database http plants. February 2. 00. 8. National Plant Data Center, Baton Rouge, LA 7. USA. 2. Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea a phytomedicinal overview. Herbal. Gram. 2. Ming DS, Hillhouse BJ, Guns ES, et al. Bioactive compounds from Rhodiola rosea Crassulaceae. Phytother Res. 2. Kucinskaite A, Poblocka Olech L, Krauze Baranowska M, Sznitowska M, Savickas A, Briedis V. Evaluation of biologically active compounds in roots and rhizomes of Rhodiola rosea L. Lithuania. Medicina. Ma G, Li W, Dou D, et al. Rhodiolosides A E, monoterpene glycosides from Rhodiola rosea. Chem Pharm Bull. Dubichev AG, Kurkin BA, Zapesochnaya GG, Vornotzov ED. Study of Rhodiola rosea root chemical composition using HPLC. Cemico Pharmaceutical J. Ganzera M, Yayla Y, Khan IA. Analysis of the marker compounds of Rhodiola rosea L. Chem Pharm Bull. Linh PT, Kim YH, Hong SP, Jian JJ, Kang JS. Quantitative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by high performance liquid chromatography. Arch Pharm Res. 2. Kelly GS. Rhodiola rosea a possible plant adaptogen. Altern Med Rev. 2. Rohloff J. Volatiles from rhizomes of Rhodiola rosea L. Phytochemistry. 2. Lee MW, Lee YA, Park HM, et al. Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis A. Bor. Pharm Res. 2. Panossian A, Wagner H. Stimulating effect of adaptogens an overview with particular reference to their efficacy following single dose administration. Phytother Res. 2. Rege NN, Thatte UM, Dahanuker SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res. 1. Boon Niermeijer EK, van den Berg A, Wikman G, Wiegant FA. National Conference CWLAWorkshop AThursday, March 3. A1 Collaboration, Resources and Resilience Family Centered Treatment in Spokane. A team of collaborators have come together to launch a family centered treatment program with housing in Spokane, Washington in 2. Based on proven models in Oregon On. Track and Los Angeles Exodus, Rising Strong will offer a safe, more effective and less costly alternative to removal for families at risk to due substance use disorder. Presenters will look at the project from several angles, and engage participants in an exercise to assess their own community needs and opportunities. Presentation highlights include  one parents journey the family centered treatment model the housing strategy and successful collaboration efforts. Presenters Mike Yeaton, Empire Health Foundation, Spokane, WA Nadine Van Stone, Catholic Charities Spokane, WA Teri Kook, Family Impact Network, Spokane, WA and Heather Cantamessa, Spokane County Superior Court Parents for Parents Program, Spokane, WAA2 The Making of an Admired Man Building a Stronger Family. The purpose of this workshop is to inspire and encourage men to understand and embrace the personal Quality, Behavior, Characteristics QBC that inspire others to Admire them, as a man. Women will also be inspired by the revelations explored in this workshop. Mothers, wives, sisters, aunts, grandmothers and the like will benefit equally by understanding  the QBCs they can encourage the men in their life to embrace. The presenter has spared no effort in researching existing scholarly and common sense literature on various topics around male studies and leadership. Presenters Chris L. Hickey, Sr., Admired Man Leadership Insititute, Inglewood, CAA3 Behavioral Interventionist Program Keeping Youth in Homes and Out of Congregate Care. The Behavioral Interventionist Program is an intensive, individualized approach to treatment and support services for the needs of children with severe emotionalbehavioral issues, without the need to remove children from their families for placement in congregate care. Crisis de escalation and trauma informed care that a facility offers, done in the home, allows them to better heal. Mental health needs among children is a great threat to stability and permanency. For parents trying to create a stable and supportive home, inpatient treatment is a last resort however, few options exist to support families when behavioremotional challenges become too much to handle. Presenters Kelsi Green, Foster. Adopt Connect, Independence, MO and Danielle Tomasi, Foster. Adopt Connect SWMO, Springfield, MOA4 The Brave. Life Intervention Youth Voice Choice Opportunities and Challenges. Westchester Building Futures WBF is a federally funded, multi year initiative which seeks to eliminate youth homelessness among at risk youth with foster care histories. Through WBFs person centered, multi dimensional intervention, The Brave. Life Intervention BLI, WBF is working to transform the way our child welfare, housing, employment and education systems respond to childhood trauma and challenges concerning the transition to adulthood. This workshop will highlight lessons learned in Phase I Planning and lessons applied in Phase II Implementation, as well as BLI key processes and outcomes, including but not limited to BLIs Peer to Peer Training Fusion blueprint model. Presenters Commissioner Kevin Mc. Guire, Westchester County Department of Social Services, White Plains, NY and Francie Zimmerman and Ruby Rivera, Center for the Study of Social Policy, Washington, DCA5 Juvenile Justice Reform in Indian Country  Best Practices and Programs toward Increasing Use of Non Detention Alternatives. This workshop will summarize the work of the Association on American Indian Affairs AAIA, under the auspices of the Annie E. Casey Foundations Juvenile Detention Alternatives Initiatives JDAI, to address the disproportionate rate of Native American youth in detention. The workshop will describe the findings of AAIAs research about best practices and programs in Indian Country that have proven effective in addressing this important issue as well as the challenges that tribal governments, communities, families, and youth continue to face. Discussion of opportunities for improving outcomes for Native youth will also be discussed. Presenters Faith Roessel, Association on American Indian Affairs, Rockville, MD and Kimberly A. Dutcher, Phoenix, AZA6 New Directions for the Kinship Care Recommendations for Federal Policy. This panel presentation offers an in depth understanding and discussion on new directions for kinship care practice and policy. In September 2. University at Albany, NYS Kinship Navigator, and Child Welfare League of America that produced a White Paper focusing on 6 specific areas for consideration 1 boundaries of kinship care, 2 the nature of permanency, 3 financial assistance for kinship families, 4 a comprehensive kinship system of care, 5 financing kinship services, and 6 a future research agenda. This panel presentation is an overview of the culmination of collaborative efforts to improve kinship care. Presenters Mark Testa, University of North Carolina at Chapel Hill, NC Gerard Wallace, New York State Kinship Navigator, Delmar, NY Eunju Lee, School of Social Welfare, State University of New York at Albany, NY Charlene Ingram, CWLA,Erial, NJ and Angie Schwartz, Alliance for Childrens Rights, Los Angeles, CAA7 Transforming Organizations to Become SOGIE Sexual Orientation, Gender Identity Gender Expression Affirming. Child welfare reforms throughout the country are mandating that all children be affirmed, and respected and their families supported. This workshop presentation will address how to transform your agency in becoming affirming and develop programs that will address the needs, well being and permanency of LGBTQ and gender non conforming children and their families. This workshop will also discuss the intersection between race, culture, ethnicity and SOGIE and the necessity to address every aspect of each child. Presenters Vida K. Khavar, Family Builders by Adoption, Oakland, CA A8 Bringing the CWLA National Blueprint to Life Using what we Know Works from Implementation Science. CWLA has been developing an Implementation Guide for the National Blueprint for Excellence in Child Welfare. CWLA has organized the Standards from the National Blueprint using the principles and practices from implementation science to facilitate individuals, organizations and communities use and application to drive improved outcomes for children, youth, and families. In this workshop session participants will learn more about the NIRN implementation framework and stage based approach and how it is applied to effectively implement and meet the standards from the National Blueprint. This interactive session will show participants how to use the components of the Implementation Guide in their organizations and communities to build on what they are already doing to achieve the vision of the National Blueprint for all children, youth, and families.